How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Document

    Has all of the relevant evidence been taken into account?

  • Question on Document

    Are the summaries of clinical and cost effectiveness reasonable interpretations of the evidence?

  • Question on Document

    Are the recommendations sound and a suitable basis for guidance to the NHS?

  • Question on Document

    Are there any equality issues that need special consideration and are not covered in the medical technology consultation document?
The content on this page is not current guidance and is only for the purposes of the consultation process.

EARLY VALUE ASSESSMENT PROGRAMME

Closed for comments This consultation ended on at   Request commenting lead permission

4 Committee members and NICE project team

Committee members

This topic was considered by NICE's medical technologies advisory committee, which is a standing advisory committee of NICE.

Committee members are asked to declare any interests in the technology to be evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.

The minutes of the medical technologies advisory committee meetings, which include the names of the members who attended and their declarations of interests, are posted on the NICE website.

Additional specialist committee members took part in the discussions and provided expert advice for this topic:

Specialist committee members

Dr Adrian Chudyk
NIHR Clinical Lecturer in General Practice, Keele University

Mr Ben Wanless
Consultant Physiotherapist, St George's University Hospital NHS Trust

Dr Christopher McCarthy
Associate Professor of Physiotherapy (Reader)/ Clinical Fellow, Manchester Metropolitan University

Ms Doré Young
Advanced MSK Physiotherapy Practitioner, Manchester University NHS Foundation Trust

Prof Jonathan Hill
Professor of Physiotherapy, Keele University

Ms Suzanne Mcllroy
Consultant Physiotherapist, King's College Hospital NHS Foundation Trust

Iain Neilson
Lay member

Vivian Brown
Lay member

NICE project team

Each early value assessment topic is assigned to a team consisting of 1 or more health technology assessment analysts (who act as technical leads for the topic), a health technology assessment adviser and a project manager.

Oyewumi Afolabi and Evan Campbell
Health technology assessment analyst

Kimberley Carter
Health technology assessment adviser

Catherine Pank
Project manager

ISBN: